A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.
A Randomized Trial to Determine the Efficacy and Safety of Coartemether and Artekin for the Treatment of Acute Falciparum and Vivax Malaria in Timika, Papua
Sponsor: Menzies School of Health Research
This NA trial investigates Falciparum Malaria and Vivax Malaria and is currently completed. Menzies School of Health Research leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Aug 2020 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jul 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Menzies School of Health Research
- National Health and Medical Research Council, Australia
- National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
- Wellcome Trust
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Timika, Indonesia